Actively Recruiting
Two Schemes Response in Multiple Myeloma
Led by Hospital General de Mexico · Updated on 2024-10-02
83
Participants Needed
1
Research Sites
49 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Retrospective study based on medical records of patients with multiple myeloma, eligible for stem cell transplantation, who received, first-line, the VTD or TD combination.
CONDITIONS
Official Title
Two Schemes Response in Multiple Myeloma
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Clinical records of patients eligible for transplant based on functional status who received combination drug treatment.
You will not qualify if you...
- Incomplete clinical records
- Patients who abandoned or could not continue treatment due to economic or distance issues
- Patients who had severe sepsis before starting treatment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hospital General de Mexico Dr. Eduardo Liceaga
Mexico City, Mexico City, Mexico, 06720
Actively Recruiting
Research Team
C
Christian O Ramos Peñafiel, PhD
CONTACT
A
Adán G Gallardo Rodriguez, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here